PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
05-May-2020 Nordic Nanovector Announces Changes to its Executive Management Team Nordic Nanovector
05-May-2020 CEL-SCI’s Pivotal Phase 3 Study Has Reached the Required Number of Events to Evaluate Data for Multikine in Treatment of Head and Neck Cancer CEL-SCI Corporation
05-May-2020 Biomaterial immune control discoveries could reduce implant rejection The University of Nottingham
05-May-2020 Vaxxel acquires Transgene's DuckCelt®-T17 cell line to develop industrial-scale vaccines against respiratory viruses Vaxxel SAS
05-May-2020 Freeline receives Orphan Drug Designation from the FDA for FLT190 for the treatment of Fabry Disease Freeline
05-May-2020 Sensyne Health announces launch of new BPm-Health™ free-of-charge across NHS in response to COVID-19 pandemic Sensyne Health
05-May-2020 Vifor Pharma announces Akebia’s Positive top-line results from global phase-III program of vadadustat for treatment of anaemia due to Chronic Kidney Disease in adult dialysis-dependent patients Vifor Pharma
05-May-2020 OMRON Healthcare announces WheezeScan, world’s first wheeze detection device OMRON Healthcare
01-May-2020 Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) for Children and Adolescents With Cystic Fibrosis Between the Ages 6 Months and 18 Years With the R117H Mutation in the CFTR Gene Vertex Pharmaceuticals
30-Apr-2020 CloudLIMS Accelerates COVID-19 Testing & Research with its Preconfigured, Rapid Deployment COVID-19 LIMS CloudLIMS
30-Apr-2020 Account Executive PHARMASEAL
29-Apr-2020 BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany BioNTech SE
29-Apr-2020 SANGAMO THERAPEUTICS ANNOUNCES PRESENTATIONS AT 2020 ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY SANGAMO THERAPEUTICS
29-Apr-2020 COMMENT: BerGenBio’s bemcentinib selected for fast track as potential treatment for coronavirus (COVID-19) Mewburn
29-Apr-2020 FDA approves ONGENTYS® ▼ (opicapone) BIAL
29-Apr-2020 Audited results for the year ended 31 December 2019 and clinical development update Destiny Pharma plc
29-Apr-2020 Sanofi: Annual General Meeting of April 28, 2020 sanofi
29-Apr-2020 Bone Therapeutics secures EUR 11.0 million financing Bone Therapeutics
29-Apr-2020 Polyplus' growth investment expands partnership with Warburg Pincus and ArchiMed Polyplus-transfection
29-Apr-2020 Elasmogen Ltd to deploy their soloMER technology platform to develop tools to combat COVID-19 Elasmogen Ltd